Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
at CRAG (from basic science to applied research using plant experimental model systems, crops and farm animals) make extensive use of genomic technologies and large sets of genetic and genomic data (https
-
function. Over the years, SBS has attracted talented individuals from around the world and Singapore to join as scientific leaders and researchers. For more details, please view https://www.ntu.edu.sg/sbs
-
the University of Vienna: https://doschem.univie.ac.at/ The standard employment contract is for three years . Initially limited to 1.5 years, the employment relationship is automatically extended to three years
-
the Guilliams and the Saelens team. Research Project In this research project you will apply in vivo CRISPR screens to study the functional specialization of liver macrophages. This project is supported by an ERC
-
Using CRISPR-Cas9 to rewire photosynthesis in plants and algae School of Biosciences PhD Research Project Self Funded Prof Matt Johnson, Dr Andy Hitchcock Application Deadline: Applications
-
‑lab expertise, including Western blotting, DNA/RNA isolation, PCR and qPCR, and basic immunofluorescence imaging Experience in genetic engineering and genome editing (e.g. CRISPR). Demonstrated ability
-
for plant transformation, discovering protein-protein interactions using proximity labeling, reverse genetics - preparation of mutants by CRISPR/Cas9 systems, phenotypic analysis of mutants using mainly
-
the University of Vienna: https://doschem.univie.ac.at/ The employment duration is 3 years. Initially limited to 1.5 years, the employment relationship is automatically extended to 3 years if the employer does not
-
the University of Vienna: https://doschem.univie.ac.at/ The employment duration is 3 years. Initially limited to 1.5 years, the employment relationship is automatically extended to 3 years if the employer does not
-
-leukemia (e.g. Beneyto-Calabuig et al., Cell Stem Cell 2023 ). A specific focus is the use of genetic screens (E.g. CRISPR screens, Perturb-Seq, MPRA) in primary hematopoietic stem cell models